These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 32330184)

  • 1. A retrospective cohort study evaluating correlates of deep tissue infections among patients enrolled in opioid agonist treatment using administrative data in Ontario, Canada.
    Morin KA; Prevost CR; Eibl JK; Franklyn MT; Moise AR; Marsh DC
    PLoS One; 2020; 15(4):e0232191. PubMed ID: 32330184
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A cohort study evaluating the association between concurrent mental disorders, mortality, morbidity, and continuous treatment retention for patients in opioid agonist treatment (OAT) across Ontario, Canada, using administrative health data.
    Morin KA; Eibl JK; Gauthier G; Rush B; Mushquash C; Lightfoot NE; Marsh DC
    Harm Reduct J; 2020 Jul; 17(1):51. PubMed ID: 32703310
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Retrospective Cohort Study Comparing In-Person and Telemedicine-Based Opioid Agonist Treatment in Ontario, Canada, Using Administrative Health Data.
    Morin KA; Parrotta MD; Eibl JK; Marsh DC
    Eur Addict Res; 2021; 27(4):268-276. PubMed ID: 33706309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluating the effectiveness of concurrent opioid agonist treatment and physician-based mental health services for patients with mental disorders in Ontario, Canada.
    Morin KA; Eibl JK; Caswell JM; Rush B; Mushquash C; Lightfoot NE; Marsh DC
    PLoS One; 2020; 15(12):e0243317. PubMed ID: 33338065
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluating the association between urine drug screening frequency and retention in opioid agonist treatment in Ontario, Canada: a retrospective cohort study.
    Morin KA; Dabous JR; Vojtesek F; Marsh D
    BMJ Open; 2022 Oct; 12(10):e060857. PubMed ID: 36223960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. One-Year Mortality After Emergency Department Visit for Nonfatal Opioid Poisoning: A Population-Based Analysis.
    Leece P; Chen C; Manson H; Orkin AM; Schwartz B; Juurlink DN; Gomes T
    Ann Emerg Med; 2020 Jan; 75(1):20-28. PubMed ID: 31561997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concurrent psychiatry for patients enrolled in opioid agonist treatment: a propensity score matched cohort study in Ontario Canada.
    Morin KA; Eibl JK; Caswell JM; Gauthier G; Rush B; Mushquash C; Lightfoot NE; Marsh DC
    Subst Abuse Treat Prev Policy; 2019 Jun; 14(1):29. PubMed ID: 31242949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measuring treatment attrition at various stages of engagement in Opioid Agonist Treatment in Ontario Canada using a cascade of care framework.
    Tahsin F; Morin KA; Vojtesek F; Marsh DC
    BMC Health Serv Res; 2022 Apr; 22(1):490. PubMed ID: 35413980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of timing of methadone initiation on perinatal outcomes following delivery among pregnant women on methadone maintenance therapy in Ontario.
    Guan Q; Sproule BA; Vigod SN; Cadarette SM; Greaves S; Martins D; Gomes T
    Addiction; 2019 Feb; 114(2):268-277. PubMed ID: 30276907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incident opioid drug use and adverse respiratory outcomes among older adults with COPD.
    Vozoris NT; Wang X; Fischer HD; Bell CM; O'Donnell DE; Austin PC; Stephenson AL; Gill SS; Rochon PA
    Eur Respir J; 2016 Sep; 48(3):683-93. PubMed ID: 27418553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cohort profile: Development and profile of a population-based, retrospective cohort of diagnosed people living with HIV in Ontario, Canada (Ontario HIV Laboratory Cohort).
    Liu J; Wilton J; Sullivan A; Marchand-Austin A; Rachlis B; Giles M; Light L; Sider D; Kroch AE; Gilbert M;
    BMJ Open; 2019 May; 9(5):e027325. PubMed ID: 31133591
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of opioid dispensings and concurrent gastrointestinal medications in an elderly population from Ontario, Canada.
    Williams R; Bosnic N; Duncan AW; Brogan M; Cook SF
    J Opioid Manag; 2008; 4(4):193-200. PubMed ID: 18837202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effectiveness of telemedicine-delivered opioid agonist therapy in a supervised clinical setting.
    Eibl JK; Gauthier G; Pellegrini D; Daiter J; Varenbut M; Hogenbirk JC; Marsh DC
    Drug Alcohol Depend; 2017 Jul; 176():133-138. PubMed ID: 28535455
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of cocaine use in patients enrolled in opioid agonist therapy in Ontario, Canada.
    Franklyn AM; Eibl JK; Gauthier GJ; Pellegrini D; Lightfoot NE; Marsh DC
    Int J Drug Policy; 2017 Oct; 48():1-8. PubMed ID: 28666202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Persistence with opioids post discharge from hospitalisation for surgery in Australian adults: a retrospective cohort study.
    Roughead EE; Lim R; Ramsay E; Moffat AK; Pratt NL
    BMJ Open; 2019 Apr; 9(4):e023990. PubMed ID: 30992289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluating the Impact of Prescribed Versus Nonprescribed Benzodiazepine Use in Methadone Maintenance Therapy: Results From a Population-based Retrospective Cohort Study.
    Eibl JK; Wilton AS; Franklyn AM; Kurdyak P; Marsh DC
    J Addict Med; 2019; 13(3):182-187. PubMed ID: 30543543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trends in Hospitalizations for Serious Infections Among People With Opioid Use Disorder in Ontario, Canada.
    Gomes T; Kitchen SA; Tailor L; Men S; Murray R; Bayoumi AM; Campbell T; Young S; Kolla G
    J Addict Med; 2022 Jul-Aug 01; 16(4):433-439. PubMed ID: 34711742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patterns of physician prescribing for opioid maintenance treatment in Ontario, Canada in 2014.
    Guan Q; Khuu W; Spithoff S; Kiran T; Kahan M; Tadrous M; Martins D; Leece P; Gomes T
    Drug Alcohol Depend; 2017 Aug; 177():315-321. PubMed ID: 28733101
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Are infants exposed to methadone in utero at an increased risk for mortality?
    Kelly LE; Rieder MJ; Bridgman-Acker K; Lauwers A; Madadi P; Koren G
    J Popul Ther Clin Pharmacol; 2012; 19(2):e160-5. PubMed ID: 22580362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in and characteristics of admissions to treatment related to problematic prescription opioid use in Ontario, 2004-2009.
    Fischer B; Nakamura N; Rush B; Rehm J; Urbanoski K
    Drug Alcohol Depend; 2010 Jun; 109(1-3):257-60. PubMed ID: 20197216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.